|
1
|
Knops RR, van Dalen EC, Mulder RL,
Leclercq E, Knijnenburg SL, Kaspers GJ, Pieters R, Caron HN and
Kremer LC: The volume effect in paediatric oncology: A systematic
review. Ann Oncol. 24:1749–1753. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rainusso N, Wang LL and Yustein JT: The
adolescent and young adult with cancer: State of the art-bone
tumors. Curr Oncol Rep. 15:296–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuijjer ML, Hogendoorn PC and
Cleton-Jansen AM: Genome-wide analyses on high-grade osteosarcoma:
Making sense of a genomically most unstable tumor. Int J Cancer.
133:2512–2521. 2013.PubMed/NCBI
|
|
5
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen C, Wang W, Tao L, Liu B, Yang Z and
Tao H: Chloroquine blocks the autophagic process in
cisplatin-resistant osteosarcoma cells by regulating the expression
of p62/SQSTM1. Int J Mol Med. 32:448–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang CZ, Zhang X, Li H, Tao YQ, Tao LJ,
Yang ZR, Zhou XP, Shi ZL and Tao HM: Gallic acid induces the
apoptosis of human osteosarcoma cells in vitro and in vivo via the
regulation of mitogen-activated protein kinase pathways. Cancer
Biother Radiopharm. 27:701–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong WG, Lin JL, Niu QX, Wang HM, Zhou YC,
Chen SY and Liang GW: Paeoniflorin diminishes ConA-induced IL-8
production in primary human hepatic sinusoidal endothelial cells in
the involvement of ERK1/2 and Akt phosphorylation. Int J Biochem
Cell Biol. 62:93–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu S, Sun W, Wei W, Wang D, Jin J, Wu J,
Chen J, Wu H and Wang Q: Involvement of the prostaglandin E
receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Anticancer Drugs. 24:140–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu JT, He W, Song SS and Wei W:
Paeoniflorin inhibited the tumor invasion and metastasis in human
hepatocellular carcinoma cells. Bratisl Lek Listy. 115:427–433.
2014.PubMed/NCBI
|
|
11
|
Zhang L and Zhang S: Modulating Bcl-2
family proteins and caspase-3 in induction of apoptosis by
paeoniflorin in human cervical cancer cells. Phytother Res.
25:1551–1557. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang LL, Zhang SL and Wang SZ: Relevant
study on apoptosis of cervical cancer HeLa cells induced by
paeoniflorin. Zhonghua Yi Xue Za Zhi. 90:3371–3375. 2010.(In
Chinese). PubMed/NCBI
|
|
13
|
Fang S, Zhu W, Zhang Y, Shu Y and Liu P:
Paeoniflorin modulates multidrug resistance of a human gastric
cancer cell line via the inhibition of NF-κB activation. Mol Med
Rep. 5:351–356. 2012.PubMed/NCBI
|
|
14
|
Zheng YB, Xiao GC, Tong SL, Ding Y, Wang
QS, Li SB and Hao ZN: Paeoniflorin inhibits human gastric carcinoma
cell proliferation through up-regulation of microRNA-124 and
suppression of PI3K/Akt and STAT3 signaling. World J Gastroenterol.
21:7197–7207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu H, Li W, Wang T, Shu Y and Liu P:
Paeoniflorin suppress NF-kappaB activation through modulation of I
kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human
gastric carcinoma cells. Biomed Pharmacother. 62:659–666. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Zhou H, Wang CX, Li YS, Xie HY,
Luo JD and Zhou Y: Paeoniflorin inhibits growth of human colorectal
carcinoma HT 29 cells in vitro and in vivo. Food Chem Toxicol.
50:1560–1567. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hung JY, Yang CJ, Tsai YM, Huang HW and
Huang MS: Antiproliferative activity of paeoniflorin is through
cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway
in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol
Physiol. 35:141–147. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang S and Liu W: Paeoniflorin inhibits
proliferation and promotes apoptosis of multiple myeloma cells via
its effects on microRNA29b and matrix metalloproteinase2. Mol Med
Rep. 14:2143–2149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu Q, Chen GL, Li YJ, Chen Y and Lin FZ:
Paeoniflorin inhibits macrophage-mediated lung cancer metastasis.
Chin J Nat Med. 13:925–932. 2015.PubMed/NCBI
|
|
20
|
Nie XH, Ou-yang J, Xing Y, Li DY, Dong XY,
Liu RE and Xu RX: Paeoniflorin inhibits human glioma cells via
STAT3 degradation by the ubiquitin-proteasome pathway. Drug Des
Devel Ther. 9:5611–5622. 2015.PubMed/NCBI
|
|
21
|
Vairapandi M, Balliet AG, Hoffman B and
Liebermann DA: GADD45b and GADD45g are cdc2/cyclinB1 kinase
inhibitors with a role in S and G2/M cell cycle checkpoints induced
by genotoxic stress. J Cell Physiol. 192:327–338. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li M, Stefansson B, Wang W, Schaefer EM
and Brautigan DL: Phosphorylation of the Pro-X-Thr-Pro site in
phosphatase inhibitor-2 by cyclin-dependent protein kinase during
M-phase of the cell cycle. Cell Signal. 18:1318–1326. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sabour Alaoui S, Dessirier V, de Araujo E,
Alexaki VI, Pelekanou V, Lkhider M, Stathopoulos EN, Castanas E,
Bagot M, Bensussan A and Tsapis A: TWEAK affects keratinocyte G2/M
growth arrest and induces apoptosis through the translocation of
the AIF protein to the nucleus. PloS One. 7:e336092012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Khanal P, Savage P, She YM, Cyr TD
and Yang X: YAP-induced resistance of cancer cells to antitubulin
drugs is modulated by a Hippo-independent pathway. Cancer Res.
74:4493–4503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dalvai M, Mondesert O, Bourdon JC,
Ducommun B and Dozier C: Cdc25B is negatively regulated by p53
through Sp1 and NF-Y transcription factors. Oncogene. 30:2282–2288.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang W, Liu Y, Zhao N, Chen H, Qiao L,
Zhao W and Chen JJ: Role of Cdk1 in the p53-independent abrogation
of the postmitotic checkpoint by human papillomavirus E6. J Virol.
89:2553–2562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang CZ, Zhang JK, Shi ZL, Liu B, Shen CQ
and Tao HM: Matrine induces caspase-dependent apoptosis in human
osteosarcoma cells in vitro and in vivo through the upregulation of
Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemother
Pharmacol. 69:317–331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tao LJ, Zhou XD, Shen CC, Liang CZ, Liu B,
Tao Y and Tao HM: Tetrandrine induces apoptosis and triggers a
caspase cascade in U2-OS and MG-63 cells through the intrinsic and
extrinsic pathways. Mol Med Rep. 9:345–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang SJ, Lee SA, Park MG, Kim JS, Yu SK,
Kim CS, Kim JS, Kim SG, Oh JS, Kim HJ, et al: Induction of
apoptosis by diphenyldifluoroketone in osteogenic sarcoma cells is
associated with activation of caspases. Oncol Rep. 31:2286–2292.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sairanen T, Szepesi R,
Karjalainen-Lindsberg ML, Saksi J, Paetau A and Lindsberg PJ:
Neuronal caspase-3 and PARP-1 correlate differentially with
apoptosis and necrosis in ischemic human stroke. Acta Neuropathol.
118:541–552. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Llambi F, Moldoveanu T, Tait SW,
Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP and Green DR:
A unified model of mammalian BCL-2 protein family interactions at
the mitochondria. Mol Cell. 44:517–531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kvansakul M and Hinds MG: The Bcl-2
family: Structures, interactions and targets for drug discovery.
Apoptosis. 20:136–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grohm J, Plesnila N and Culmsee C: Bid
mediates fission, membrane permeabilization and peri-nuclear
accumulation of mitochondria as a prerequisite for oxidative
neuronal cell death. Brain Behav Immun. 24:831–838. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan XJ and Whang YE: PTEN sensitizes
prostate cancer cells to death receptor-mediated and drug-induced
apoptosis through a FADD-dependent pathway. Oncogene. 21:319–327.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suh DH, Kim MK, Kim HS, Chung HH and Song
YS: Mitochondrial permeability transition pore as a selective
target for anti-cancer therapy. Front Oncol. 3:412013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jonas EA, Porter GA Jr, Beutner G,
Mnatsakanyan N and Alavian KN: Cell death disguised: The
mitochondrial permeability transition pore as the c-subunit of the
F(1)F(O) ATP synthase. Pharmacol Res. 99:382–392. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pang X, Moussa SH, Targy NM, Bose JL,
George NM, Gries C, Lopez H, Zhang L, Bayles KW, Young R and Luo X:
Active Bax and Bak are functional holins. Genes Dev. 25:2278–2290.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lindenboim L, Ferrando-May E, Borner C and
Stein R: Non-canonical function of Bax in stress-induced nuclear
protein redistribution. Cell Mol Life Sci. 70:3013–3027. 2013.
View Article : Google Scholar : PubMed/NCBI
|
